In the lungs, GLP-1RAs attenuate acute lung injury by maintaining alveolar-capillary barrier function, reducing neutrophil infiltration, and promoting surfactant protein expression, potentially through suppression of NLRP3 inflammasome activity
2001;280:E4049
Anyone experiencing persistent numbness, weakness, or pain should treat it as a reason to stop and seek medical evaluation
There are few large, randomized studies using regenerative aesthetics in patients taking GLP-1 RAs
GLP AI focuses on your success by connecting the dots between your dose days, nutrition habits, and symptom patterns
Some research has shown that even in the absence of functional beta-3 receptors, acute AOD-9604 administration still increased energy expenditure and fat oxidation, suggesting the peptide may influence brown fat or thermogenic pathways through additional mechanisms